Asia Pacific Blood Purification Equipment Market By Product, By Indication, By End User, By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026

The Asia Pacific Blood Purification Equipment Market is expected to witness market growth of 6% CAGR during the forecast period (2020-2026).

In the last few years, plenty of therapeutic technologies & advanced blood purification machines have penetrated the market. Rising knowledge-based and awareness regarding hematology & pathophysiology due to high R&D along with remarkable advancements in bio separation methods is some of the aspects that is expected to support the growth of the blood purification equipment market.

Moreover, the latest developments in pathophysiology of various diseases have brought a surge in the adoption of blood purification techniques has and hence, fueled the demand for blood purification equipment. The findings of various pathophysiology agents in the bloodstream & their essential role in the pathophysiology of associated diseases such as systematic inflammatory response syndrome, autoimmune diseases, dialysis-related amyloidosis (DRA), & cancer is expected to open growth avenues for the blood purification equipment market during the forecast period.

The demand for blood purification techniques has observed substantial development in the past few years and is extensively utilized to treat various disorders, which cannot be treated by traditional methods, such as drug administration and surgery. The advancements made by bio separation methods, such as dialysis, filtration, and adsorptions are one of the leading trends that is expected to fuel the growth of the blood purification equipment market during the forecast period. Blood purification techniques provide superior efficiency in the quick and direct removal of pathogenic agents due to which, their adoption is increasing in various parts of the world.

The China market dominated the Asia Pacific Hospitals and Clinics Market by Country in 2019, and is expected to continue to be a dominant market till 2026. The India market is anticipated to grow at a CAGR of 7.2% during (2020 - 2026). Additionally, The Japan market is showcasing a CAGR of 7.3% during (2020 - 2026).

The Portable market dominated the Malaysia Blood Purification Equipment Market by Product in 2019, thereby, achieving a market value of $289.7 million by 2026. The Stationary market is expected to exhibit a CAGR of 8.1% during (2020 - 2026).

Based on Product, the market is segmented into Portable and Stationary. Based on Indication, the market is segmented into Renal Diseases, Sepsis and Other Equipments. Based on End User, the market is segmented into Dialysis Centers, Hospitals and Clinics and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, Shanwaishan Medical Group, Jafron Biomedical Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.

Scope of the Study

Market Segmentation:

By Product

• Portable
• Stationary

By Indication

• Renal Diseases
• Sepsis
• Other Equipments

By End User

• Dialysis Centers
• Hospitals and Clinics
• Other End Users

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• B. Braun Melsungen AG
• Baxter International, Inc.
• Asahi Kasei Corporation
• Nikkiso Co., Ltd.
• Kaneka Corporation
• Cerus Corporation
• Shanwaishan Medical Group
• Jafron Biomedical Co., Ltd.
• Infomed SA
• Fresenius SE & Co. KGaA

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free